{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:29:20Z","timestamp":1792600160959,"version":"4.5.0"},"reference-count":48,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017346","name":"Nippon Boehringer Ingelheim Co. Ltd","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Scleroderma and Related Disorders"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Interstitial lung disease is a common complication and cause of mortality in patients with systemic sclerosis. Pharmacotherapy for systemic sclerosis\u2013associated interstitial lung disease was mostly limited to off-label use of immunosuppressive drugs until recently, when two drugs became licenced for this condition: nintedanib, an antifibrotic agent, and tocilizumab, a targeted anti-inflammatory\/immunomodulatory therapy licenced in the United States. In chronic diseases, communication between physicians and patients is associated with treatment adherence, patient satisfaction, and clinical outcomes. This review of physician\u2013patient communication during systemic sclerosis\u2013associated interstitial lung disease treatment covers key issues identified by studies in Japan, the United States and Europe, as well as the clinical experience, opinion, and recommendations of the physician and patient advocate authors. As discussed, recent surveys in Japan found low usage of guideline-recommended immunosuppressive drugs for systemic sclerosis\u2013associated interstitial lung disease and physician dissatisfaction with them. Physicians and patients in Japan also had differing perceptions about what had been said during consultations, suggesting the need to improve physician\u2013patient communication. Other studies in Japan, the United States and Europe made several key findings. Notably, most patients feel uneasy at the diagnosis of systemic sclerosis\u2013associated interstitial lung disease, and both physicians and patients avoid discussing prognosis and mortality. Furthermore, a white-coat barrier hinders patients raising topics important to them. For physicians, listening and empathy may be key for building rapport with patients. Importantly, physicians and patients have different cognitive models of systemic sclerosis\u2013associated interstitial lung disease, creating communication challenges. There are also similarities and differences in clinical practice and physician\u2013patient communication between countries that are important to consider. From the patient\u2019s perspective, key factors include the quality of the first consultation, physician empathy and active listening, and space to ask questions. Efforts to improve physician\u2013patient communication include peer mentoring, patient self-education (such as the \u2018Self-Manage Scleroderma\u2019 website from the University of Michigan), and shared decision-making \u2013 although not all activities will necessarily be appropriate everywhere.<\/jats:p>","DOI":"10.1177\/23971983251324803","type":"journal-article","created":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T02:04:35Z","timestamp":1742522675000},"page":"224-236","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Physician\u2013patient communication in the treatment of systemic sclerosis\u2013associated interstitial lung disease: A narrative review and recommendations"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-6136","authenticated-orcid":false,"given":"Masataka","family":"Kuwana","sequence":"first","affiliation":[{"name":"Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiko","family":"Saito","sequence":"additional","affiliation":[{"name":"Nippon Boehringer Ingelheim Co., Ltd, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Farrington","sequence":"additional","affiliation":[{"name":"Patient advocate"},{"name":"Scleroderma and Raynaud\u2019s UK, London, UK"},{"name":"Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Galetti","sequence":"additional","affiliation":[{"name":"Patient advocate"},{"name":"Federation of European Scleroderma Associations aisbl, Saint-Maur, Belgium"},{"name":"Gruppo Italiano per la Lotta alla Sclerodermia, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3975-8938","authenticated-orcid":false,"given":"Christopher P","family":"Denton","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology, Division of Medicine, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-4453","authenticated-orcid":false,"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[{"name":"Scleroderma Program and Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163894"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S191418"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1177\/2397198320915042"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.resinv.2021.04.011"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/23971983211064463"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211448"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000027"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.05.010"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S226695"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-0980-7"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2019.1696505"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6307"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00152106"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903076"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30318-0"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2023.2176303"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(19)30144-4"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202306-1113ST"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25348"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25347"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-226430"},{"issue":"1","key":"e_1_3_3_24_2","first-page":"25","article-title":"Physician-patient communication in the primary care office: a systematic review","volume":"15","author":"Beck RS","year":"2002","unstructured":"Beck RS, Daughtridge R, Sloane PD. Physician-patient communication in the primary care office: a systematic review. J Am Board Fam Pract 2002; 15(1): 25\u201338.","journal-title":"J Am Board Fam Pract"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000004323"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100001906"},{"key":"e_1_3_3_27_2","unstructured":"Japan Intractable Disease Center. Number of specific medical expenses (designated intractable diseases) beneficiary certificate holders. https:\/\/www.nanbyou.or.jp\/wp-content\/uploads\/2022\/03\/koufu20211.pdf (accessed 18 January 2023)."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02078-5"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa547"},{"issue":"12","key":"e_1_3_3_30_2","first-page":"1539","article-title":"Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States","volume":"26","author":"Fan Y","year":"2020","unstructured":"Fan Y, Bender S, Shi W, et al. Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States. J Manag Care Spec Pharm 2020; 26(12): 1539\u20131547.","journal-title":"J Manag Care Spec Pharm"},{"key":"e_1_3_3_31_2","first-page":"719","article-title":"Survey of physicians and patients regarding their understanding of the disease and their communication in management of systemic sclerosis-associated interstitial lung disease","volume":"43","author":"Kuwana M","year":"2022","unstructured":"Kuwana M, Baba S, Saito A. Survey of physicians and patients regarding their understanding of the disease and their communication in management of systemic sclerosis-associated interstitial lung disease. Ther Res 2022; 43: 719\u2013746.","journal-title":"Ther Res"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05371-2"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-017-0868-5"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.03.016"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13357"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1037\/0033-2909.111.2.256"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-090413-123522"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1992370"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1992369"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05063-x"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/nursrep14010043"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101707"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1603-4"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1093\/medlaw\/fwaa008"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/1179548420913281"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02292-3"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24596"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-018-4016-2"}],"container-title":["Journal of Scleroderma and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23971983251324803","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23971983251324803","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23971983251324803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:53:04Z","timestamp":1777981984000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23971983251324803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1177\/23971983251324803"],"URL":"https:\/\/doi.org\/10.1177\/23971983251324803","relation":{},"ISSN":["2397-1983","2397-1991"],"issn-type":[{"value":"2397-1983","type":"print"},{"value":"2397-1991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]}}}